Track topics on Twitter Track topics that are important to you
BTG PLC granted Carrick Therapeutics Ltd. exclusive global rights to BTG945 for ovarian cancer. Financial terms were not disc...
Original Article: Carrick licenses ovarian cancer project from BTGNEXT ARTICLE
Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...